AYTU.US Aytu BioScience Inc

Healthcare Pharmaceuticals USA Stocks
1.80 USD
Close of Nov 13, 2026
1.75 3.07
Market cap
USD 19.6M
P/E
-
P/B
0.55x
ROE
-40.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is AYTU.US undervalued?

Graham number

The Graham number of Aytu BioScience Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Aytu BioScience Inc fundamental analysis

No fundamental analysis for Aytu BioScience Inc yet.

Aytu BioScience Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Aytu BioScience Inc

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT A central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 17 years o…

Full company profile